Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Vitrolife receives CE mark for SpermFreeze solution

Vitrolife has received CE mark for SpermFreeze Solution, which is used for freeze storage of sperm, and is thereby approved for sales within the European Economic Area (EEA).

The freezing of sperm is used in connection with in-vitro fertilization (IVF) treatment for patients who find it difficult to produce sperm samples or who are diagnosed as having cancer.

Vitrolife’s SpermFreeze Solution has been developed to retain sperm DNA integrity and function after freeze storage, which has also been demonstrated in a clinical evaluation.

Vitrolife CEO Magnus Nilsson said the company has worked for and will continue to drive the question of the importance of CE marked products becoming a requirement in fertility treatment, with a view to increasing patient safety.